tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

GHRS Stock Latest News

Psychedelic: atai, Beckly Psytech to combine in all-share transaction
The FlyPsychedelic: atai, Beckly Psytech to combine in all-share transaction
1d ago
ATAI
CMND
GH Research assumed with an Overweight at Cantor Fitzgerald
PremiumThe Fly
GH Research assumed with an Overweight at Cantor Fitzgerald
2d ago
GHRS
GH Research to Present at ASCP Meeting on Breakthrough Depression Treatment
PremiumCompany Announcements
GH Research to Present at ASCP Meeting on Breakthrough Depression Treatment
10d ago
6K
GHRS
GH Research to Present at ASCP Meeting on Depression Treatments
PremiumCompany Announcements
GH Research to Present at ASCP Meeting on Depression Treatments
16d ago
6K
GHRS
GH Research Showcases Promising Depression Treatment Data at ASCP Meeting
PremiumCompany Announcements
GH Research Showcases Promising Depression Treatment Data at ASCP Meeting
22d ago
6K
GHRS
GH Research announces acceptance of presentation at ASCP
PremiumThe FlyGH Research announces acceptance of presentation at ASCP
22d ago
GHRS
GH Research: Promising Clinical Results and Strong Financial Position Justify Buy Rating
Premium
Ratings
GH Research: Promising Clinical Results and Strong Financial Position Justify Buy Rating
28d ago
GHRS
Psychedelic: Compass, GH Research, MindMed report quarterly earnings
Premium
The Fly
Psychedelic: Compass, GH Research, MindMed report quarterly earnings
29d ago
CMPS
CYBN
GH Research reports Q1 EPS (19c), consensus (20c)
PremiumThe Fly
GH Research reports Q1 EPS (19c), consensus (20c)
29d ago
GHRS
GH Research Reports Q1 2025 Financial Results Amidst Ongoing Challenges
PremiumCompany Announcements
GH Research Reports Q1 2025 Financial Results Amidst Ongoing Challenges
29d ago
6K
GHRS
Psychedelic: Exclusive talk with retreat provider ONE Retreats
PremiumThe Fly
Psychedelic: Exclusive talk with retreat provider ONE Retreats
2M ago
ATAI
CMND
Psychedelic: Exclusive talk with biotech company Clearmind Medicine
PremiumThe Fly
Psychedelic: Exclusive talk with biotech company Clearmind Medicine
3M ago
ATAI
CMND
Psychedelic: atai Life Sciences, NRx report quarterly results
PremiumThe FlyPsychedelic: atai Life Sciences, NRx report quarterly results
3M ago
ATAI
CMND
Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial
Premium
The Fly
Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial
3M ago
ATAI
CMND
Guggenheim starts GH Research at Buy, sees long-term upside potential
Premium
The Fly
Guggenheim starts GH Research at Buy, sees long-term upside potential
3M ago
GHRS
GH Research initiated with a Buy at Guggenheim
PremiumThe Fly
GH Research initiated with a Buy at Guggenheim
3M ago
GHRS
GH Research initiated with an Outperform at RBC Capital
PremiumThe Fly
GH Research initiated with an Outperform at RBC Capital
3M ago
GHRS
GH Research PLC Reports 2024 Financial Results and Clinical Progress
PremiumCompany Announcements
GH Research PLC Reports 2024 Financial Results and Clinical Progress
3M ago
GHRS
GH Research’s Promising Growth Potential: Buy Rating Backed by Strong Clinical Data and Financial Position
PremiumRatings
GH Research’s Promising Growth Potential: Buy Rating Backed by Strong Clinical Data and Financial Position
3M ago
GHRS
Optimistic Buy Rating for GH Research Driven by Promising Clinical Data and Strong Financial Outlook
PremiumRatingsOptimistic Buy Rating for GH Research Driven by Promising Clinical Data and Strong Financial Outlook
3M ago
GHRS
Promising Trial Results and Strong Financials Justify Buy Rating for GH Research
Premium
Ratings
Promising Trial Results and Strong Financials Justify Buy Rating for GH Research
3M ago
GHRS
Psychedelic: GH Research, Compass Pathways report earnings results
Premium
The Fly
Psychedelic: GH Research, Compass Pathways report earnings results
3M ago
ATAI
CMND

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >